Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Biologics Drug market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Biologics Drug market. Detailed analysis of key players, along with key growth strategies adopted by Biologics Drug industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
AbbVie
Pfizer.
Amgen
GlaxoSmithKline
Bristol-Myers Squibb
F Hoffmann-La Roche
Sanofi
Eli Lilly and Company
Johnson & Johnson
F. Hoffmann-La Roche
By Type:
Monoclonal Antibodies (mAbs)
Therapeutic Proteins
Vaccines
By End-User:
Online Sales
Pharmacy
Others
By Region:
-
Hokkaido
-
Tohoku
-
Kanto
-
Chubu
-
Kinki
-
Chugoku
-
Shikoku
-
Kyushu
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Biologics Drug Market
-
1.3 Market Segment by Type
1.3.1 Japan Biologics Drug Market Size and Growth Rate of Monoclonal Antibodies (mAbs) from 2014 to 2026
1.3.2 Japan Biologics Drug Market Size and Growth Rate of Therapeutic Proteins from 2014 to 2026
1.3.3 Japan Biologics Drug Market Size and Growth Rate of Vaccines from 2014 to 2026
-
1.4 Market Segment by Application
1.4.1 Japan Biologics Drug Market Size and Growth Rate of Online Sales from 2014 to 2026
1.4.2 Japan Biologics Drug Market Size and Growth Rate of Pharmacy from 2014 to 2026
1.4.3 Japan Biologics Drug Market Size and Growth Rate of Others from 2014 to 2026
-
1.5 Market Segment by Regions
-
1.5.1 Hokkaido Biologics Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Tohoku Biologics Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Kanto Biologics Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Chubu Biologics Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Kinki Biologics Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Chugoku Biologics Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Shikoku Biologics Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Kyushu Biologics Drug Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Biologics Drug Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Biologics Drug by Major Types
3.4.1 Market Size and Growth Rate of Monoclonal Antibodies (mAbs)
3.4.2 Market Size and Growth Rate of Therapeutic Proteins
3.4.3 Market Size and Growth Rate of Vaccines
4 Segmentation of Biologics Drug Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Biologics Drug by Major End-Users
4.4.1 Market Size and Growth Rate of Biologics Drug in Online Sales
4.4.2 Market Size and Growth Rate of Biologics Drug in Pharmacy
4.4.3 Market Size and Growth Rate of Biologics Drug in Others
5 Market Analysis by Regions
-
5.1 Japan Biologics Drug Production Analysis by Regions
-
5.2 Japan Biologics Drug Consumption Analysis by Regions
6 Hokkaido Biologics Drug Landscape Analysis
-
6.1 Hokkaido Biologics Drug Landscape Analysis by Major Types
-
6.2 Hokkaido Biologics Drug Landscape Analysis by Major End-Users
7 Tohoku Biologics Drug Landscape Analysis
-
7.1 Tohoku Biologics Drug Landscape Analysis by Major Types
-
7.2 Tohoku Biologics Drug Landscape Analysis by Major End-Users
8 Kanto Biologics Drug Landscape Analysis
-
8.1 Kanto Biologics Drug Landscape Analysis by Major Types
-
8.2 Kanto Biologics Drug Landscape Analysis by Major End-Users
9 Chubu Biologics Drug Landscape Analysis
-
9.1 Chubu Biologics Drug Landscape Analysis by Major Types
-
9.2 Chubu Biologics Drug Landscape Analysis by Major End-Users
10 Kinki Biologics Drug Landscape Analysis
-
10.1 Kinki Biologics Drug Landscape Analysis by Major Types
-
10.2 Kinki Biologics Drug Landscape Analysis by Major End-Users
11 Chugoku Biologics Drug Landscape Analysis
-
11.1 Chugoku Biologics Drug Landscape Analysis by Major Types
-
11.2 Chugoku Biologics Drug Landscape Analysis by Major End-Users
12 Shikoku Biologics Drug Landscape Analysis
-
12.1 Shikoku Biologics Drug Landscape Analysis by Major Types
-
12.2 Shikoku Biologics Drug Landscape Analysis by Major End-Users
13 Kyushu Biologics Drug Landscape Analysis
-
13.1 Kyushu Biologics Drug Landscape Analysis by Major Types
-
13.2 Kyushu Biologics Drug Landscape Analysis by Major End-Users
14 Major Players Profiles
14.1 AbbVie
14.1.1 AbbVie Company Profile and Recent Development
14.1.2 Market Performance
14.1.3 Product and Service Introduction
14.2 Pfizer.
14.2.1 Pfizer. Company Profile and Recent Development
14.2.2 Market Performance
14.2.3 Product and Service Introduction
14.3 Amgen
14.3.1 Amgen Company Profile and Recent Development
14.3.2 Market Performance
14.3.3 Product and Service Introduction
14.4 GlaxoSmithKline
14.4.1 GlaxoSmithKline Company Profile and Recent Development
14.4.2 Market Performance
14.4.3 Product and Service Introduction
14.5 Bristol-Myers Squibb
14.5.1 Bristol-Myers Squibb Company Profile and Recent Development
14.5.2 Market Performance
14.5.3 Product and Service Introduction
14.6 F Hoffmann-La Roche
14.6.1 F Hoffmann-La Roche Company Profile and Recent Development
14.6.2 Market Performance
14.6.3 Product and Service Introduction
14.7 Sanofi
14.7.1 Sanofi Company Profile and Recent Development
14.7.2 Market Performance
14.7.3 Product and Service Introduction
14.8 Eli Lilly and Company
14.8.1 Eli Lilly and Company Company Profile and Recent Development
14.8.2 Market Performance
14.8.3 Product and Service Introduction
14.9 Johnson & Johnson
14.9.1 Johnson & Johnson Company Profile and Recent Development
14.9.2 Market Performance
14.9.3 Product and Service Introduction
14.10 F. Hoffmann-La Roche
14.10.1 F. Hoffmann-La Roche Company Profile and Recent Development
14.10.2 Market Performance
14.10.3 Product and Service Introduction
The List of Tables and Figures (Totals 95 Figures and 154 Tables)
Figure Japan Biologics Drug Market Size and Growth Rate of Monoclonal Antibodies (mAbs) from 2014 to 2026
Figure Japan Biologics Drug Market Size and Growth Rate of Therapeutic Proteins from 2014 to 2026
Figure Japan Biologics Drug Market Size and Growth Rate of Vaccines from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
Figure Japan Biologics Drug Market Size and Growth Rate of Online Sales from 2014 to 2026
Figure Japan Biologics Drug Market Size and Growth Rate of Pharmacy from 2014 to 2026
Figure Japan Biologics Drug Market Size and Growth Rate of Others from 2014 to 2026
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure Hokkaido Biologics Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Tohoku Biologics Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kanto Biologics Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chubu Biologics Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kinki Biologics Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chugoku Biologics Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Shikoku Biologics Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kyushu Biologics Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Biologics Drug Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Biologics Drug
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Biologics Drug by Different Types from 2014 to 2026
-
Table Consumption Share of Biologics Drug by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of Monoclonal Antibodies (mAbs)
Figure Market Size and Growth Rate of Therapeutic Proteins
Figure Market Size and Growth Rate of Vaccines
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Biologics Drug by Different End-Users from 2014 to 2026
-
Table Consumption Share of Biologics Drug by Different End-Users from 2014 to 2026
Figure Japan Biologics Drug Market Size and Growth Rate of Online Sales from 2014 to 2026
Figure Japan Biologics Drug Market Size and Growth Rate of Pharmacy from 2014 to 2026
Figure Japan Biologics Drug Market Size and Growth Rate of Others from 2014 to 2026
-
Table Japan Biologics Drug Production by Regions
-
Table Japan Biologics Drug Production Share by Regions
-
Figure Japan Biologics Drug Production Share by Regions in 2014
-
Figure Japan Biologics Drug Production Share by Regions in 2018
-
Figure Japan Biologics Drug Production Share by Regions in 2026
-
Table Japan Biologics Drug Consumption by Regions
-
Table Japan Biologics Drug Consumption Share by Regions
-
Figure Japan Biologics Drug Consumption Share by Regions in 2014
-
Figure Japan Biologics Drug Consumption Share by Regions in 2018
-
Figure Japan Biologics Drug Consumption Share by Regions in 2026
-
Table Hokkaido Biologics Drug Consumption by Types from 2014 to 2026
-
Table Hokkaido Biologics Drug Consumption Share by Types from 2014 to 2026
-
Figure Hokkaido Biologics Drug Consumption Share by Types in 2014
-
Figure Hokkaido Biologics Drug Consumption Share by Types in 2018
-
Figure Hokkaido Biologics Drug Consumption Share by Types in 2026
-
Table Hokkaido Biologics Drug Consumption by End-Users from 2014 to 2026
-
Table Hokkaido Biologics Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Hokkaido Biologics Drug Consumption Share by End-Users in 2014
-
Figure Hokkaido Biologics Drug Consumption Share by End-Users in 2018
-
Figure Hokkaido Biologics Drug Consumption Share by End-Users in 2026
-
Table Tohoku Biologics Drug Consumption by Types from 2014 to 2026
-
Table Tohoku Biologics Drug Consumption Share by Types from 2014 to 2026
-
Figure Tohoku Biologics Drug Consumption Share by Types in 2014
-
Figure Tohoku Biologics Drug Consumption Share by Types in 2018
-
Figure Tohoku Biologics Drug Consumption Share by Types in 2026
-
Table Tohoku Biologics Drug Consumption by End-Users from 2014 to 2026
-
Table Tohoku Biologics Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Tohoku Biologics Drug Consumption Share by End-Users in 2014
-
Figure Tohoku Biologics Drug Consumption Share by End-Users in 2018
-
Figure Tohoku Biologics Drug Consumption Share by End-Users in 2026
-
Table Kanto Biologics Drug Consumption by Types from 2014 to 2026
-
Table Kanto Biologics Drug Consumption Share by Types from 2014 to 2026
-
Figure Kanto Biologics Drug Consumption Share by Types in 2014
-
Figure Kanto Biologics Drug Consumption Share by Types in 2018
-
Figure Kanto Biologics Drug Consumption Share by Types in 2026
-
Table Kanto Biologics Drug Consumption by End-Users from 2014 to 2026
-
Table Kanto Biologics Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Kanto Biologics Drug Consumption Share by End-Users in 2014
-
Figure Kanto Biologics Drug Consumption Share by End-Users in 2018
-
Figure Kanto Biologics Drug Consumption Share by End-Users in 2026
-
Table Chubu Biologics Drug Consumption by Types from 2014 to 2026
-
Table Chubu Biologics Drug Consumption Share by Types from 2014 to 2026
-
Figure Chubu Biologics Drug Consumption Share by Types in 2014
-
Figure Chubu Biologics Drug Consumption Share by Types in 2018
-
Figure Chubu Biologics Drug Consumption Share by Types in 2026
-
Table Chubu Biologics Drug Consumption by End-Users from 2014 to 2026
-
Table Chubu Biologics Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Chubu Biologics Drug Consumption Share by End-Users in 2014
-
Figure Chubu Biologics Drug Consumption Share by End-Users in 2018
-
Figure Chubu Biologics Drug Consumption Share by End-Users in 2026
-
Table Kinki Biologics Drug Consumption by Types from 2014 to 2026
-
Table Kinki Biologics Drug Consumption Share by Types from 2014 to 2026
-
Figure Kinki Biologics Drug Consumption Share by Types in 2014
-
Figure Kinki Biologics Drug Consumption Share by Types in 2018
-
Figure Kinki Biologics Drug Consumption Share by Types in 2026
-
Table Kinki Biologics Drug Consumption by End-Users from 2014 to 2026
-
Table Kinki Biologics Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Kinki Biologics Drug Consumption Share by End-Users in 2014
-
Figure Kinki Biologics Drug Consumption Share by End-Users in 2018
-
Figure Kinki Biologics Drug Consumption Share by End-Users in 2026
-
Table Chugoku Biologics Drug Consumption by Types from 2014 to 2026
-
Table Chugoku Biologics Drug Consumption Share by Types from 2014 to 2026
-
Figure Chugoku Biologics Drug Consumption Share by Types in 2014
-
Figure Chugoku Biologics Drug Consumption Share by Types in 2018
-
Figure Chugoku Biologics Drug Consumption Share by Types in 2026
-
Table Chugoku Biologics Drug Consumption by End-Users from 2014 to 2026
-
Table Chugoku Biologics Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Chugoku Biologics Drug Consumption Share by End-Users in 2014
-
Figure Chugoku Biologics Drug Consumption Share by End-Users in 2018
-
Figure Chugoku Biologics Drug Consumption Share by End-Users in 2026
-
Table Shikoku Biologics Drug Consumption by Types from 2014 to 2026
-
Table Shikoku Biologics Drug Consumption Share by Types from 2014 to 2026
-
Figure Shikoku Biologics Drug Consumption Share by Types in 2014
-
Figure Shikoku Biologics Drug Consumption Share by Types in 2018
-
Figure Shikoku Biologics Drug Consumption Share by Types in 2026
-
Table Shikoku Biologics Drug Consumption by End-Users from 2014 to 2026
-
Table Shikoku Biologics Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Shikoku Biologics Drug Consumption Share by End-Users in 2014
-
Figure Shikoku Biologics Drug Consumption Share by End-Users in 2018
-
Figure Shikoku Biologics Drug Consumption Share by End-Users in 2026
-
Table Kyushu Biologics Drug Consumption by Types from 2014 to 2026
-
Table Kyushu Biologics Drug Consumption Share by Types from 2014 to 2026
-
Figure Kyushu Biologics Drug Consumption Share by Types in 2014
-
Figure Kyushu Biologics Drug Consumption Share by Types in 2018
-
Figure Kyushu Biologics Drug Consumption Share by Types in 2026
-
Table Kyushu Biologics Drug Consumption by End-Users from 2014 to 2026
-
Table Kyushu Biologics Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Kyushu Biologics Drug Consumption Share by End-Users in 2014
-
Figure Kyushu Biologics Drug Consumption Share by End-Users in 2018
-
Figure Kyushu Biologics Drug Consumption Share by End-Users in 2026
Table Company Profile and Development Status of AbbVie
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie
Figure Sales and Growth Rate Analysis of AbbVie
Figure Revenue and Market Share Analysis of AbbVie
Table Product and Service Introduction of AbbVie
Table Company Profile and Development Status of Pfizer.
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer.
Figure Sales and Growth Rate Analysis of Pfizer.
Figure Revenue and Market Share Analysis of Pfizer.
Table Product and Service Introduction of Pfizer.
Table Company Profile and Development Status of Amgen
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen
Figure Sales and Growth Rate Analysis of Amgen
Figure Revenue and Market Share Analysis of Amgen
Table Product and Service Introduction of Amgen
Table Company Profile and Development Status of GlaxoSmithKline
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline
Figure Sales and Growth Rate Analysis of GlaxoSmithKline
Figure Revenue and Market Share Analysis of GlaxoSmithKline
Table Product and Service Introduction of GlaxoSmithKline
Table Company Profile and Development Status of Bristol-Myers Squibb
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb
Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb
Figure Revenue and Market Share Analysis of Bristol-Myers Squibb
Table Product and Service Introduction of Bristol-Myers Squibb
Table Company Profile and Development Status of F Hoffmann-La Roche
Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche
Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche
Figure Revenue and Market Share Analysis of F Hoffmann-La Roche
Table Product and Service Introduction of F Hoffmann-La Roche
Table Company Profile and Development Status of Sanofi
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
Figure Sales and Growth Rate Analysis of Sanofi
Figure Revenue and Market Share Analysis of Sanofi
Table Product and Service Introduction of Sanofi
Table Company Profile and Development Status of Eli Lilly and Company
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly and Company
Figure Sales and Growth Rate Analysis of Eli Lilly and Company
Figure Revenue and Market Share Analysis of Eli Lilly and Company
Table Product and Service Introduction of Eli Lilly and Company
Table Company Profile and Development Status of Johnson & Johnson
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson
Figure Sales and Growth Rate Analysis of Johnson & Johnson
Figure Revenue and Market Share Analysis of Johnson & Johnson
Table Product and Service Introduction of Johnson & Johnson
Table Company Profile and Development Status of F. Hoffmann-La Roche
Table Sales, Revenue, Sales Price and Gross Margin Analysis of F. Hoffmann-La Roche
Figure Sales and Growth Rate Analysis of F. Hoffmann-La Roche
Figure Revenue and Market Share Analysis of F. Hoffmann-La Roche
Table Product and Service Introduction of F. Hoffmann-La Roche
-
